An established diagnostic agent supporting clinical measurement and near-infrared fluorescence visualisation using compatible imaging systems. Compatible near-infrared imaging systems detect and display ICG fluorescence, providing visual information for diagnostic assessment and procedural guidance.
THIS INFORMATION IS INTENDED FOR UK HEALTHCARE PROFESSIONALS ONLY.
Type: Prescription Only Medicine (POM)
Product: Verdye 5 mg/ml powder for solution for injection
Designed in collaboration with cardiologists to solve the most common challenges in radial hemostasis.
Verdye ICG supports application-specific dosing across its approved diagnostic uses. The prescribed dose is determined by the indication and, where applicable, the patient’s body weight, in accordance with the SmPC.
The vial format supports straightforward reconstitution and withdrawal of the prescribed dose, helping healthcare professionals manage preparation for each procedure.
The five-year shelf life helps reduce the risk of stock expiry while supporting inventory management and procurement planning when stored in accordance with the SmPC.
Compatible near-infrared imaging systems detect and display ICG fluorescence, providing visual information for diagnostic assessment and procedural guidance. Over 20 years of pharmacovigilance data* and experience are complemented by Kimal’s dedicated field-based Clinical Specialists, who support theatre sessions, teaching and training.
Verdye ICG is being used by surgeons worldwide for a range of procedures and has over 11,000 published articles on use and applications.** THIS INFORMATION IS INTENDED FOR UK HEALTHCARE PROFESSIONALS ONLY. Active substance: Indocyanine Green (lyophilised powder) Purpose of use: Diagnostic procedures using fluorescence imaging Pharmaceutical form: Powder for solution for injection: Dark-green power UK presentation: 5 × 25 mg vials Concentration: 5 mg/ml Shelf-life: 5 yearsDry powder of Verdye ICG must be reconstituted with water for injections immediately before use.
The 25 mg vial is reconstituted with 5 ml of water for injections, producing a solution containing 5 mg/ml of indocyanine green.
Verdye ICG may be administered intravenously, intradermally, subcutaneously or peritumorally, depending on the indication. Dose, route and method of administration must follow the Summary of Product Characteristics. Total daily dose: • Adults, elderly, adolescents 11-18 years: The total dose of Verdye should be kept below 5 mg/kg body weight. Safety: • Nausea – Very rare (˂1/10,000) • Urticaria – Very Rare (˂1/10,000) • Anaphylactoid or anaphylactic reactions – Very Rare (˂1/10,000) Refer to the Summary of Product Characteristics for complete safety information, including contraindications, warnings, precautions and adverse reactions. REGULATORY INFO Adverse reactions should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse reactions should also be reported to info@diagnosticgreen.com This website contains promotional material for VerdyeTM, a prescription-only medicine. Always read the label and the Prescribing information carefully before use. Information about this product, including adverse reactions, precautions, contra-indications, and method of use can be found at https://diagnosticgreen.com/row/icgpharmaceutical- product/. Please consult the Summary of Product Characteristics and patient information leaflet for full prescribing information. Marketing authorisation holder Diagnostic Green Limited, Athlone Business and Technology Park, Garrycastle, Athlone, N37 F786, Ireland PL 56699/0001 NHS pricing: £152.98 NHS list price For more information, please contact us using the enquiry form here. REFERENCES & SOURSES: **Diagnostic Green pharmacovigilance data **Source: PubMedConnect with our product specialists for bulk orders and institutional inquiries.
There is no information to display.
| Product Code (Sterile) | Product Description |
|---|---|
| PICG0025UK | Verdye (Indocyanine Green) 5mg/ml Injection |
